Jarema Kochan
Senior Director, Clinical Biomarkers, Clinical Development Eikon Therapeutics
Seminars
Wednesday 7th October 2026
Panel Discussion: Transforming Patient Enrolment & Monitoring Through Innovation in Liquid Biopsy Analytes, Detection Sensitivity & Data Interpretation
12:50 pm
- What are the most fit-for-purpose recent innovations in liquid biopsy biomarkers, and how can these be robustly validated and integrated into clinical trial designs?
- How can drug-diagnostic stakeholders build collaborative, scalable frameworks to advance liquid biopsy technologies, particularly in improving standardization, and harmonization? And who should contribute to this framework?
